Skip to search formSkip to main contentSkip to account menu

olodaterol / tiotropium

Known as: OLODATEROL/TIOTROPIUM, tiotropium-olodaterol 
National Institutes of Health

Related topics

Related topics

9 relations
28 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose Inhalerolodateroltiotropium

Broader (3)

BenzoxazinesDrug Combinationstiotropium bromide

Narrower (2)

Spiolto RespimatStiolto Respimat

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The impact of grouping patients by the 2017 GOLD COPD strategy on response to therapy: post hoc results from the TONADO tiotropium+olodaterol trials
Introduction: In the 2017 GOLD COPD strategy the classification of patients by assessment of symptoms and history of exacerbation… 
Review
2015
Review
2015
Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease
The recent Global Initiative for Chronic Obstructive Lung Disease (GOLD) chronic obstructive pulmonary disease (COPD) guidelines… 
Review
2015
Review
2015
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
Olodaterol (BI 1744 CL) is a novel, once-daily long-acting β2-agonist (LABA) designed with the aim of improving β2-adrenoreceptor… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)